Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Palla, R.

Search results

  • RSS Feed
(1 - 11 of 11)
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
Peyvandi, F.; Miri, S.; Bucciarelli, P.; Valsecchi, C.; Schiavone, L.; Boscarino, M.; ... ; SIPPET Grp 2020
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
Article / Letter to editor
open access
We investigated longitudinally the behaviour of anti-factor VIII (anti-FVIII) IgG subclasses for 6 months from inhibitor development in 43 patients from the Survey of Inhibitors in Plasma-Products... Show moreWe investigated longitudinally the behaviour of anti-factor VIII (anti-FVIII) IgG subclasses for 6 months from inhibitor development in 43 patients from the Survey of Inhibitors in Plasma-Products Exposed Toddlers (SIPPET) trial who developed persistent or transient inhibitors. We first analysed 43 patients within 60 days post inhibitor detection. Then, 14 of these 43 patients were studied at five time points over 6 months. Our study showed that during the first 60 days, the risk of inhibitor persistence increased with the concomitant presence of an increasing number of IgG subclasses. Over the 6-month period post inhibitor detection, only the IgG2 subclass could be considered a hallmark of inhibitor persistence. Show less
PERFORMANCE OF A CLINICAL RISK PREDICTION MODEL FOR INHIBITOR FORMATION IN SEVERE HEMOPHILIA A
Hassan, S.; Palla, R.; Valsecchi, C.; Garagiola, I.; El-Beshlawy, A.; Elalfy, M.; ... ; Peyvandi, F. 2019
PERFORMANCE OF A CLINICAL RISK PREDICTION MODEL FOR INHIBITOR FORMATION IN SEVERE HEMOPHILIA A
Other
metadata only
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis
Messori, A.; Peyvandi, F.; Trippoli, S.; Palla, R.; Rosendaal, F.R.; Mannucci, P.M. 2018
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis
Article / Letter to editor
open access
Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey
Peyvandi, F.; Palla, R.; Franchi, C.; Nobili, A.; Rosendaal, F.R.; Mannucci, P.M. 2018
Choices of factor VIII products in previously untreated patients with haemophilia A: A global survey
Article / Letter to editor
metadata only
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
Peyvandi, F.; Cannavo, A.; Garagiola, I.; Palla, R.; Mannucci, P.M.; Rosendaal, F.R.; Sippet Study Grp 2018
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
Article / Letter to editor
metadata only
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
Rosendaal, F.R.; Palla, R.; Garagiola, I.; Mannucci, P.M.; Peyvandi, F.; SIPPET Study Grp 2017
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
Article / Letter to editor
metadata only
SIPPET: methodology, analysis and generalizability
Peyvandi, F.; Mannucci, P.M.; Palla, R.; Rosendaal, F.R. 2017
SIPPET: methodology, analysis and generalizability
Article / Letter to editor
metadata only
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
Cannavo, A.; Valsecchi, C.; Garagiola, I.; Palla, R.; Mannucci, P.M.; Rosendaal, F.R.; Peyvandi, F. 2017
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
Article / Letter to editor
metadata only
ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
Bettoni, G.; Palla, R.; Valsecchi, C.; Consonni, D.; Lotta, L.A.; Trisolini, S.M.; ... ; Peyvandi, F. 2012
ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
Article / Letter to editor
metadata only
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
Peyvandi, F.; Palla, R.; Menegatti, M.; Siboni, S.M.; Halimeh, S.; Faeser, B.; ... ; En Rbd Grp 2012
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders
Article / Letter to editor
metadata only
Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results Foam the European Network of Rare Bleeding Disorders (EN-RBD)
Peyvandi, F.; Palla, R.; Menegatti, M.; Siboni, S.M.; Halimeh, S.; Faeser, B.; ... ; Rosendaal, F.R. 2011
Coagulation Factor Activity Level and Clinical Bleeding Severity in Rare Bleeding Disorders: Results Foam the European Network of Rare Bleeding Disorders (EN-RBD)
Article / Letter to editor
metadata only